ICU Medical Q3 2021 Earnings Report
Key Takeaways
ICU Medical announced financial results for the quarter ended September 30, 2021, with revenue of $336.1 million, GAAP gross profit of $127.8 million, and GAAP net income of $31.1 million, or $1.43 per diluted share.
Third quarter revenue was $336.1 million, compared to $318.6 million in the same period last year.
GAAP gross profit for the third quarter of 2021 was $127.8 million, as compared to $113.9 million in the same period last year.
GAAP net income for the third quarter of 2021 was $31.1 million, or $1.43 per diluted share, as compared to GAAP net income of $25.0 million, or $1.16 per diluted share, for the third quarter of 2020.
Adjusted diluted earnings per share for the third quarter of 2021 were $2.07 as compared to $1.90 for the third quarter of 2020.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
The company did not provide specific forward guidance in this earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income